Generation of refractory schizophrenia patient-derived induced pluripotent stem cell line UJS']JSi001-A

被引:4
|
作者
Sun, Jing [1 ]
Zhang, Xiaoya [1 ]
Cong, Qijie [1 ]
Wang, Cong [2 ]
Chen, Dong [1 ]
Wang, Yincheng [1 ]
Wang, Xiaowen [1 ]
Yi, Zhenghui [3 ]
Qin, Shengying [2 ]
机构
[1] Jiangsu Univ, Sch Pharm, Neurobiol & Mitochondrial Key Lab, Zhenjiang 212013, Jiangsu, Peoples R China
[2] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 201100, Peoples R China
基金
中国博士后科学基金;
关键词
D O I
10.1016/j.scr.2019.101460
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Schizophrenia is considered one of the most serious mental disorders nowadays. Approximately 30-60% of people with schizophrenia do not present adequate response to drug treatment and persist with symptoms of the disease; they are known as refractory schizophrenic people. We generated induced pluripotent stem cells (iPSCs) from a refractory schizophrenia patient by electroporation of peripheral blood mononuclear cells (PBMC) with episomal plasmids encoding OCT 4, SOX 2, NANOG, LIN 28, KLF 4 and LMYC. The resulting iPSCs had normal karyotype, were free of genomically integrated episomal plasmids, expressed pluripotency markers, and could differentiate into the three germ layers in vivo.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Generation and characterization of induced pluripotent stem cell line (IGIBi001-A) from a sickle cell anemia patient with homozygous β-globin mutation
    Bhargava, Nupur
    Jaitly, Shashank
    Goswami, Sangam Giri
    Jain, Suman
    Chakraborty, Debojyoti
    Ramalingam, Sivaprakash
    STEM CELL RESEARCH, 2019, 39
  • [42] Current status and future prospects of patient-derived induced pluripotent stem cells
    Zhiqiang Wang
    Jing Zheng
    Ruolang Pan
    Ye Chen
    Human Cell, 2021, 34 : 1601 - 1616
  • [43] Modeling Retinal Dystrophies Using Patient-Derived Induced Pluripotent Stem Cells
    Wahlin, Karl J.
    Maruotti, Julien
    Zack, Donald J.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 157 - 164
  • [44] Patient-derived induced pluripotent stem cells in cancer research and precision oncology
    Papapetrou, Eirini P.
    NATURE MEDICINE, 2016, 22 (12) : 1392 - 1401
  • [45] Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies
    Xixi Du
    Jack M. Parent
    Current Neurology and Neuroscience Reports, 2015, 15
  • [46] Patient-derived induced pluripotent stem cells for modelling genetic retinal dystrophies
    Foltz, Leah P.
    Clegg, Dennis O.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2019, 68 : 54 - 66
  • [47] Current status and future prospects of patient-derived induced pluripotent stem cells
    Wang, Zhiqiang
    Zheng, Jing
    Pan, Ruolang
    Chen, Ye
    HUMAN CELL, 2021, 34 (06) : 1601 - 1616
  • [48] Retinoblastoma Organoids Generated from Patient-derived Induced Pluripotent Stem cells
    Li, Yanping
    Jin, Li-Wen
    Wang, Ya-Ting
    Wang, Wen
    Zhang, Xiao
    Jin, Kang-Xin
    Jin, Zi-Bing
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [49] Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells
    Ling, Chen
    Liu, Zunpeng
    Song, Moshi
    Zhang, Weiqi
    Wang, Si
    Liu, Xiaoqian
    Ma, Shuai
    Sun, Shuhui
    Fu, Lina
    Chu, Qun
    Belmonte, Juan Carlos Izpisua
    Wang, Zhaoxia
    Qu, Jing
    Yuan, Yun
    Liu, Guang-Hui
    PROTEIN & CELL, 2019, 10 (04) : 249 - 271
  • [50] Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies
    Du, Xixi
    Parent, Jack M.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2015, 15 (10)